FDA officials argue for retaining advisory committee votes, welcome return to face-to-face meetings
Regulatory NewsJoanne S. Eglovitch
Health Authority meeting and communication strategyMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States